About Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization
Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization is a rare disease catalogued by Orphanet (ORPHA:69063). It is associated with the MME gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization trials.
Search ClinicalTrials.gov for "Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization" or filter by Orphanet code ORPHA:69063 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization. Updated daily.